SMTL ID : 4izy.1

Crystal structure of JNK1 in complex with JIP1 peptide and 4-{4-[4-(4-Methanesulfonyl-piperidin-1-yl)-indol-1-yl]-pyrimidin-2-ylamino}-cyclohexan

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.30 Å

Oligo State

hetero-1-1-mer

Ligands

1 x 1J2: trans-4-[(4-{4-[4-(methylsulfonyl)piperidin-1-yl]-1H-indol-1-yl}pyrimidin-2-yl)amino]cyclohexanol(Non-covalent)

1J2.1: 18 residues within 4Å: Chain A: I.32, G.33, S.34, G.35, A.36, Q.37, G.38, V.40, A.53, K.55, I.86, E.109, L.110, M.111, D.112, N.114, V.158, L.168 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:I.32, A:V.40, A:A.53, A:V.158, A:L.168 Hydrogen bonds: A:M.111, A:M.111 Water bridges: A:N.114, A:N.114

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Gong, L. et al., Development of indole/indazole-aminopyrimidines as inhibitors of c-Jun N-terminal kinase (JNK): optimization for JNK potency and physicochemical properties. Bioorg.Med.Chem.Lett. (2013)

Release Date

2013-12-18

Peptides

Mitogen-activated protein kinase 8: A
C-Jun-amino-terminal kinase-interacting protein 1: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Mitogen-activated protein kinase 8

C-Jun-amino-terminal kinase-interacting protein 1

Related Entries With Identical Sequence